News & Media

2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002

To download and view any of the documents listed below, click on the links. To view or print the Portable Document Format (PDF) files, you will need Adobe Acrobat Viewer installed on your system.

If you do not have the latest Adobe Viewer, please download it here before you attempt to open the desired file.

Please click here to listen to archived boardrooom radio presentations

2008
December 24, 2008		2009 shareholder notice of meeting for Arana Therapeutics Limited
December 15, 2008		AAH - CEO Profile - Dr Steffen Nock, Acting CEO
December 11, 2008		AAH - Arana Commences International Phase II Rheumatoid Arthritis Trial - Dr David Fuller, Chief Medical Officer
December 11, 2008		Arana commences international Phase II trial in RA
November 27, 2008		Arana Therapeutics Completes Second Project for GSK
November 26, 2008		Arana commences ART621 Phase II rheumatoid arthritis trial
November 26, 2008		Arana News - November 2008
November 19, 2008		Grand Opening Melbourne Facility: Steffen Nock & Rob Crombie Speech
November 19, 2008		Grand Opening Melbourne Facility: Innovation Minister Gavin Jennings Speech
November 19, 2008		Innovation Minister Gavin Jennings- Media Release- ANOTHER BOOST TO VICTORIAN BIOTECH INVESTMENT AND JOBS
November 13, 2008		AAH - Full Year Results 2008 - Mr Robin Beaumont, Chairman and Mr Niall Henderson, CFO
November 12, 2008		Arana Full Year results media release
November 12, 2008		Arana Full Year Results
November 12, 2008		Arana Announces Appointment of Acting CEO
November 6, 2008		Arana Announces Resignation of CEO
November 4, 2008		AAH - FDA Accepts Arana's Anti-Inflammatory IND - Dr David Fuller, Chief Medical Officer
November 3, 2008		FDA accepts Arana`s anti-inflammatory IND
October 8, 2008		Arana Strengthens Board with New Appointment
October 8, 2008		Arana Announces On-Market Share Buy-back
October 2, 2008		Arana Completes a Series of Antibodies for Vegenics
September 30, 2008		Arana Files IND for Lead Anti-Inflammatory Product ART621
September 22, 2008		Arana Updates Inflammatory Pipeline Milestones
August 28, 2008		AAH - Arana Announces Key Anti-Inflammatory Drug Milestone - Dr David Fuller, Chief Medical Officer
August 28, 2008		Arana Announces Key Anti-Inflammatory Drug Milestone
August 13, 2008		Results of meeting
August 7, 2008		AAH - Corporate Overview - Dr John Chiplin, CEO, Boardroom Radio interview
July 28, 2008		Arana Therapeutics expands clinical research team
July 14, 2008		Shareholder general meeting
July 3, 2008		Grand Opening Macquarie Park Facility: John Chiplin Speech
July 3, 2008		Grand Opening Macquarie Park Facility: Sen. Kim Carr Speech
July 3, 2008		SENATOR KIM CARR - MEDIA RELEASE AND SPEECH - NEW R&D FACILITY LEADS WAY FOR AUSTRALIAN BIOTECH SECTOR - 3 JULY 2008
June 25, 2008		Arana Half Year Report – March 2008
June 24, 2008		AAH - Discussion on the 2008 BIO International Convention in San Diego - Dr Steffen Nock, President Arana Therapeutics Inc, Boardroom Radio interview
June 5, 2008		Arana Therapeutics completes second project with CSL
June 3, 2008		Arana and Greenovation enter into a collaboration agreement
May 23, 2008		Arana 2008 Half Year Report, Boardroom Radio interview
May 21, 2008		Arana 2008 Half Year Report
April 28, 2008		AAH - Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug, Boardroom Radio interview
April 28, 2008		Excellence in Biotechnology Investment Presentation, Boardroom Radio interview
April 24, 2008		Arana and Kyowa Hakko to Co-develop Anti-Cancer Drug
April 14, 2008		Corporate presentation - April 08
March 18, 2008		Sky TV: Update on Phase II Trial Status
March 18, 2008		ARANA THERAPEUTICS LIMITED (AAH) provides the opportunity to listen to an audio broadcast with Dr John Chiplin and Dr David Fuller, Managing Director / CEO and Chief Medical Officer in a presentation titled "AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer".
March 17, 2008		Arana Announces Start of Phase II Trial for Lead Compound
February 14, 2008		Arana AGM 2008
February 4, 2008		Sky TV: ART621 Phase II set to start
February 4, 2008		Arana achieves milestone in collaboration with CSL
February 1, 2008		Arana announces sale of animal health division
January 14, 2008		Arana Therapeutics Performance Share Plan
January 11, 2008		2008 shareholder notice of meeting for Arana Therapeutics Limited
January 9, 2008		Arana announces final receipt of $17.7 million from sale of Domantis Limited
2007
December 28, 2007		Arana announces resignation of director
December 17, 2007		Relocation of registered office
December 11, 2007		Arana announces resignation of director
December 6, 2007		IBC Conference Presentation
December 5, 2007		Sky TV: ART621 Phase II Trials Set to Start
December 4, 2007		Arana Announces Phase II trials for Lead Compound ART621	TOP
November 30, 2007		AAH - Arana Therapeutics Completes Project With CSL - Mr Rob Crombie, VP Business Development
November 29, 2007		Arana Therapeutics Completes Project With CSL
November 19, 2007		Bloomberg TV: Arana Name change and ART621 Phase II Trial Announcement
November 19, 2007		Change of Director's Interest Notice
November 12, 2007		Arana investor presentation
November 9, 2007		Arana Therapeutics Reports Strong Financial
November 9, 2007		2007 Annual Results
November 8, 2007		Arana launches new business strategy
November 1, 2007		Peptech announces board changes
October 29, 2007		Peptech successfully completes Phase I trial for PN0621
October 8, 2007		Notice of General Meeting
October 2, 2007		Peptech commercialisation agreement with AVEO
September 12, 2007		Peptech signs partner to distribute Suprelorin® in Europe
August 28, 2007		Peptech pays scheme consideration to evogenix shareholders
August 27, 2007		Peptech announces director retirements
August 17, 2007		Evogenix receives court order regarding merger with Peptech
August 16, 2007		EvoGenix to commence second project with GlaxoSmithKline
August 9, 2007		Shareholders Approve Peptech-Evogenix Merger
August 9, 2007		PTD Merger Announcement on ASX
July 13, 2007		Sky News Australia Sky Business Report
July 12, 2007		Peptech presentation to eG Capital Forum
July 11, 2007		Peptech presentation to eG Capital Forum
July 5, 2007		Change in Directors Interest Notice x 2
June 28, 2007		EvoGenix Scheme Booklet
June 26, 2007		Peptech to conduct global search for new Chairman
June 22, 2007		Peptech wins Best Newcomer award 2007 at the Annual London Stock Exchange MediScience Awards
June 20, 2007		Peptech Half Year Report
June 18, 2007		Peptech renegotiates Biosceptre joint venture	TOP
June 13, 2007		Peptech establishes International Scientific Advisory Board
June 6, 2007		PTD - Merger Roadshow Presentation - Dr John Chiplin, MD; Dr Phil Jennings, Exec. Director and Dr Cliff Holloway, VP of Bus. Development
June 6, 2007		Peptech appoints Chief Medical Officer
May 22, 2007		PTD Enters Phase I Clinical Trials - Dr Phil Jennings, Executive Director
May 22, 2007		Peptech enters Phase I clinical trial of PN0621
May 21, 2007		Peptech UK roadshow presentation
May 17, 2007		Record Profit for Half Year Boardroom Radio interview
May 17, 2007		Peptech announces record profit
May 17, 2007		Peptech 2007 Half Year Results
May 16, 2007		Chairmans letter to shareholders
May 8, 2007		Notice of initial substantial holder
May 7, 2007		Peptech and Evogenix merger Boardroom Radio interview
May 7, 2007		Peptech and Evogenix merger presentation
May 7, 2007		Peptech and Evogenix merge to form antibody powerhouse
May 3, 2007		Peptech’s Pipeline Boosted With A$6.6M Government Grant
May 1, 2007		Peptech presentation
April 30, 2007		Peptech to present at key international conferences
April 5, 2007		Peptech strengthens board with new appointment
March 26, 2007		GlaxoSmithKline has confirmed that EvoGenix has successfully met and exceeded the target set for improving the binding of a therapeutic protein to its target.
March 21, 2007		Peptech Animal Health Boardroom radio interview
March 19, 2007		Suprelorin® recommendation clears path for sales in Europe
March 16, 2007		Corporate presentation
March 16, 2007		Peptech antibody technology platform breakthrough
March 14, 2007		Peptech appoints global financial adviser
February 27, 2007		EvoGenix announced a technology collaboration with Circadian-backed Vegenics Ltd.  In a non-exclusive deal, EvoGenix will apply its technology to ahelp develop an anti-cancer antibody
February 23, 2007		EvoGenix has released its accounts for the half year to December, 2006 and a report on operations for the half year
February 8, 2007		Peptech AGM February 2007
February 8, 2007		Peptech to explore private equity options
January 31, 2007		Peptech launches next generation Suprelorin12
January 24, 2007		EvoGenix has been granted a patent by the US Patent Office covering development and work with Evibodies, small antibody-like proteins for use as therapeutics or diagnostics.
January 8, 2007		Peptech realises A$178m with Domantis sale completion	TOP